DIABETES CURE?
A
possible cure of diabetes
National
Post, Friday, December 15, 2006
In a
discovery that has stunned even those behind it, scientists at a Toronto
hospital say they have proof the body's nervous system helps trigger diabetes,
opening the door to a potential near-cure of the disease that affects millions
of Canadians.
Diabetic
mice became healthy virtually overnight after researchers injected a substance
to counteract the effect of malfunctioning pain neurons in the pancreas.
"I
couldn't believe it," said Dr. Michael Salter, a pain expert at the
Hospital for Sick Children and one of the scientists. "Mice with diabetes
suddenly didn't have diabetes any more."
The
researchers caution they have yet to confirm their findings in people, but say
they expect results from human studies within a year or so. Any treatment that
may emerge to help at least some patients would likely be years away from
hitting the market.
But
the excitement of the team from Sick Kids, whose work is being published today
in the journal Cell, is almost palpable.
"I've
never seen anything like it," said Dr. Hans Michael Dosch, an immunologist
at the hospital and a leader of the studies. "In my career, this is
unique."
Their
conclusions upset conventional wisdom that Type 1 diabetes, the most serious
form of the illness that typically first appears in childhood, was solely caused
by auto-immune responses -- the body's immune system turning on itself.
They
also conclude that there are far more similarities than previously thought
between Type 1 and Type 2 diabetes, and that nerves likely play a role in other
chronic inflammatory conditions, such as asthma and Crohn's disease.
The
"paradigm-changing" study opens "a novel, exciting door to
address one of the diseases with large societal impact," said Dr. Christian
Stohler, a leading U.S. pain specialist and dean of dentistry at the University
of Maryland, who has reviewed the work.
"The
treatment and diagnosis of neuropathic diseases is poised to take a dramatic
leap forward because of the impressive research."About two million
Canadians suffer from diabetes, 10% of them with Type 1, contributing to 41,000
deaths a year.
Insulin
replacement therapy is the only treatment of Type 1, and cannot prevent many of
the side effects, from heart attacks to kidney failure.
In
Type 1 diabetes, the pancreas does not produce enough insulin to shift glucose
into the cells that need it. In Type 2 diabetes, the insulin that is produced is
not used effectively -- something called insulin resistance -- also resulting in
poor absorption of glucose.
The
problems stem partly from inflammation -- and eventual death -- of
insulin-producing islet cells in the pancreas.
Dr.
Dosch had concluded in a 1999 paper that there were surprising similarities
between diabetes and multiple sclerosis, a central nervous system disease. His
interest was also piqued by the presence around the insulin-producing islets of
an "enormous" number of nerves, pain neurons primarily used to signal
the brain that tissue has been damaged.
Suspecting
a link between the nerves and diabetes, he and Dr. Salter used an old
experimental trick -- injecting capsaicin, the active ingredient in hot chili
peppers, to kill the pancreatic sensory nerves in mice that had an equivalent of
Type 1 diabetes.
"Then
we had the biggest shock of our lives," Dr. Dosch said. Almost immediately,
the islets began producing insulin normally "It was a shock ? really out of
left field, because nothing in the literature was saying anything about
this."
It
turns out the nerves secrete neuropeptides that are instrumental in the proper
functioning of the islets. Further study by the team, which also involved the
University of Calgary and the Jackson Laboratory in Maine, found that the nerves
in diabetic mice were releasing too little of the neuropeptides, resulting in a
"vicious cycle" of stress on the islets.
So
next they injected the neuropeptide "substance P" in the pancreases of
diabetic mice, a demanding task given the tiny size of the rodent organs. The
results were dramatic.
The
islet inflammation cleared up and the diabetes was gone. Some have remained in
that state for as long as four months, with just one injection.
They
also discovered that their treatments curbed the insulin resistance that is the
hallmark of Type 2 diabetes, and that insulin resistance is a major factor in
Type 1 diabetes, suggesting the two illnesses are quite similar.
While
pain scientists have been receptive to the research, immunologists have voiced
skepticism at the idea of the nervous system playing such a major role in the
disease. Editors of Cell put the Toronto researchers through vigorous review to
prove the validity of their conclusions, though an editorial in the publication
gives a positive review of the work.
"It
will no doubt cause a great deal of consternation," said Dr. Salter about
his paper.
The
researchers are now setting out to confirm that the connection between sensory
nerves and diabetes holds true in humans. If it does, they will see if their
treatments have the same effects on people as they did on mice.
Nothing is for sure, but "there is a great deal of promise," Dr. Salter said.